Virtual screening and structure-based 3D pharmacophore approach to identify small-molecule inhibitors of SARS-CoV-2 M

COVID-19 SARS-CoV-2 Mpro binding free energy molecular dynamics structure-based 3D pharmacophore virtual screening

Journal

Journal of biomolecular structure & dynamics
ISSN: 1538-0254
Titre abrégé: J Biomol Struct Dyn
Pays: England
ID NLM: 8404176

Informations de publication

Date de publication:
2022
Historique:
pubmed: 23 10 2021
medline: 29 12 2022
entrez: 22 10 2021
Statut: ppublish

Résumé

The outbreak caused by a coronavirus 2 has required quick and potential treatment strategies. The main protease enzyme M

Identifiants

pubmed: 34676801
doi: 10.1080/07391102.2021.1993341
doi:

Substances chimiques

Peptide Hydrolases EC 3.4.-
Protease Inhibitors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

13658-13674

Auteurs

Samia A Elseginy (SA)

Molecular Modelling Lab., Biochemistry School, Bristol University, Bristol, UK.
Green Chemistry Department, Chemical Industries Research Division, National Research Centre, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH